Im Cannabis Total Cash From Financing Activities Over Time
| IMCC Stock | USD 2.44 0.15 5.79% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Im Cannabis Performance and Im Cannabis Correlation. IMCC |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Im Cannabis. If investors know IMCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Im Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.13) | Revenue Per Share 22.335 | Quarterly Revenue Growth 0.117 | Return On Assets (0.17) | Return On Equity (1.12) |
The market value of Im Cannabis Corp is measured differently than its book value, which is the value of IMCC that is recorded on the company's balance sheet. Investors also form their own opinion of Im Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Im Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Im Cannabis' market value can be influenced by many factors that don't directly affect Im Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Im Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Cash From Financing Activities Analysis
Compare Im Cannabis Corp and related stocks such as Clever Leaves Holdings, Khiron Life Sciences, and Allied Corp Total Cash From Financing Activities Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BFRI | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 13.2 M | 43.2 M | 14 M | 8.4 M | 15.2 M |
| UPC | (4.9 M) | (4.9 M) | (4.9 M) | (4.9 M) | (4.9 M) | (4.9 M) | (4.9 M) | (4.9 M) | (16 M) | 470.1 K | 26.6 M | 3.3 M | (1.4 M) | (1.6 M) | (1.5 M) |
| IXHL | 5.3 M | 7.5 M | 4.5 M | (500 K) | 944.1 K | (603.7 K) | 182.5 K | 2.6 M | 2 M | 5.1 M | 9.3 M | 41.2 M | 8.1 M | 0.0 | 0.0 |
| PAHC | 11.3 M | (8.2 M) | 10.9 M | 4.8 M | (15.4 M) | 50.4 M | (53.7 M) | (11.8 M) | (4.1 M) | 40.9 M | (17 M) | 16.3 M | 27 M | (6.8 M) | (6.4 M) |
| SUPN | 5 K | 27.1 M | 87.9 M | 62.7 M | 570 K | 1.9 M | 2.1 M | 5.7 M | 376.4 M | 3.9 M | 3.6 M | (130.4 M) | (10.5 M) | (397.9 M) | (378 M) |
Im Cannabis Corp and related stocks such as Clever Leaves Holdings, Khiron Life Sciences, and Allied Corp Total Cash From Financing Activities description
My Equities
My Current Equities and Potential Positions
| Im Cannabis Corp | IMCC |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Ontario; Canada |
| Exchange | NASDAQ Exchange |
USD 2.44
Check out Im Cannabis Performance and Im Cannabis Correlation. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Im Cannabis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.